Abstrakt: |
Keywords: Combination Therapy; Drugs and Therapies; Health and Medicine; Malaria; Mosquito-Borne Diseases; Pediatrics; Pharmaceuticals; Protozoan Infections EN Combination Therapy Drugs and Therapies Health and Medicine Malaria Mosquito-Borne Diseases Pediatrics Pharmaceuticals Protozoan Infections 2497 2497 1 10/03/23 20231006 NES 231006 2023 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Zika & Mosquito Week -- New study results on malaria have been published. Based on species-specific analysis by nested PCR, Plasmodium falciparum infection [33.6% (570/1697)] was dominant, with Plasmodium malariae, Plasmodium ovale and Plasmodium vivax infections accounting for 0.1% (1/1697), 0.0% (0/1697), and 0.0% (0/1697), respectively. [Extracted from the article] |